{"id":"W4392130094","doi":"10.1007/s12325-024-02797-x","title":"Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"Cilag; Janssen Research and Development; Genentech; Chugai Pharmaceutical; EUSA Pharma; Servier; Incyte; bluebird bio; Regeneron Pharmaceuticals; Universidad de Salamanca; Adaptive Biotechnologies; Karyopharm Therapeutics; Legend Biotech; Celgene; Cerecor; Janssen Pharmaceuticals; Yale University; Sanofi; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Hazard ratio; Confidence interval; Relative risk; Refractory (planetary science); Proportional hazards model; Multiple myeloma; Gastroenterology; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002186952,0.0002398768,0.0005084845,0.000301869,0.00003502359,0.00001410686,0.00009216594,0.00004044091,0.000009061792],"category_scores_gemma":[0.00005733057,0.0001320413,0.00004789922,0.000464841,0.0002034417,0.0002767511,0.00002460771,0.0002733549,0.000003870999],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003073049,"about_ca_system_score_gemma":0.00004908887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004322056,"about_ca_topic_score_gemma":0.000255861,"domain_scores_codex":[0.998342,0.000248548,0.0003823622,0.0003504337,0.0004004311,0.0002761854],"domain_scores_gemma":[0.9989235,0.0006469524,0.00008481569,0.0002334876,0.00005973771,0.00005146254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007087308,0.004288535,0.7341087,0.0001554095,0.0002553995,0.00006938002,0.01008266,0.00005214618,0.00008236702,0.00002985882,0.00002590437,0.2437623],"study_design_scores_gemma":[0.03448144,0.003629479,0.9559836,0.0009613497,0.00002346211,0.00000228963,0.001060621,0.0003772675,0.0008776481,0.00009086363,0.002387192,0.0001248086],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9449859,0.05253216,0.000008048418,0.0001882239,0.0001170195,0.002045162,0.00002154053,0.00001572431,0.00008622957],"genre_scores_gemma":[0.9861005,0.01331835,0.0001272082,0.00003537504,0.00001840749,0.0002843039,0.00007979394,0.00001571504,0.00002032396],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2436374,"threshold_uncertainty_score":0.538449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05978296233205799,"score_gpt":0.3848374014435362,"score_spread":0.3250544391114782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}